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Neem (Azadirachta indica A. Juss) is perhaps the most 
useful traditional medicinal plant in India. Each part 
of the neem tree has some medicinal property and is 
thus commercially exploitable. During the last five 
decades, apart from the cmistry of the neem com-
pounds, considerable progress has been achieved 
regarding the biological activity and medicinal appli-
cations of neem. It is now considered as a valuable 
source of unique natural products for development of 
medicines against various diseases and also for the 
development of industrial products. This review gives 
a bird’s eye view mainly on the biological activities of 
some of the neem compounds isolated, pharmaco-
logical actions of the neem extracts, clinical studies 
and plausible medicinal applications of neem along 
with their safety evaluation. 
MEDICINAL plants are part and parcel of human society to 
combat diseases, from the dawn of civilization. A -
dirachta indica A. Juss (syn. Melia azadirachta) is well 
known in India and its neighbouring countries for more 
than 2000 years as one of the most versatile medicinal 
plants having a wide spectrum of biological activity. A. 
indica A. Juss and M. azedarach are two closely related 
species of Meliaceae. The former is popularly known as 
Indian neem (margosa tree) or Indian lilac, and the latter 
as the Persian lilac. Neem is an evergreen tree, cultivated 
in various parts of the Indian subcontinent. Every part of 
the tree has been used as traditional medicine for house-
hold remedy against various human ailments, from 
antiquity1–6. Neem has been extensively used in ayur-
veda, unani and homoeopathic medicine and has become 
a cynosure of modern medicine. The sanskrit name of the 
neem tree is ‘Arishtha’ meaning ‘reliever of sickness’ 
and hence is considered as ‘Sarbaroganibarini’. The tree 
is still regarded as ‘village dispensary’ in India. The 
importance of the neem tree has been recognized by the 
US National Academy of Sciences, which published a 
report in 1992 entitled ‘Neem – a tree for solving global 
problems’. The advancement of neem research has earlier 
been documented7,8. 
The neem tree has been described as A. indica as early 
as 1830 by De Jussieu9 and its taxonomic position is as 
follows: 
 
Order  Rutales 
Suborder  Rutinae 
Family  Meliaceae (mahogany family) 
Subfamily  Melioideae 
Tribe  Melieae 
Genus  Azadirachta 
Species  indica 
 
The genus Azadirachta A. Juss which comprises three 
species of Indo-Malayan origin has been characterized in 
detail10,11. 
Chemical investigation on the products of the neem 
tree was extensively undertaken in the middle of the 
twentieth century. Since the early report by Siddiqui12 in 
1942 on the isolation of nimbin, the first bitter compound 
isolated from neem oil, more than 135 compounds have 
been isolated from different parts of neem and several 
reviews have also been published on the chemistry  
and structural diversity of these compounds5,6,13–19. The  
compounds have been divided into two major classes: 
isoprenoids and others18. The isoprenoids include diter-
penoids and triterpenoids containing protomeliacins, 
limonoids, azadirone and its derivatives, gedunin and  
its derivatives, vilasinin type of compounds and C-
secomeliacins such as nimbin, salanin and azadirachtin. 
The nonisoprenoids include proteins (amino acids) and 
carbohydrates (polysaccharides), sulphurous compounds, 
polyphenolics such as flavonoids and their glycosides, 
dihydrochalcone, coumarin and tannins, aliphatic com-
pounds, etc. The details of the chemistry of various 
compounds falling under these groups have already been 
reviewed17,18. Only a few compounds whose bioactivity 
has been studied are presented here. As the pesticidal and 
antifeedant activities of azadirachtin and the related com-
pounds have been reviewed earlier17–19, they have been 
excluded from this review. 
Biological activity of some neem compounds 
Although a large number of compounds have been 
isolated from various parts of neem, a few of them have *For correspondence. (e-mail: ranajitb@yahoo.com) 
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been studied for biological activity as shown in Table 1. 
The structure of some of thesebioactive compounds has 
been presented in Figure 1. 
Nimbidin, a major crude bitter principle extracted from 
the oil of seed kernels of A. indica demonstrated several 
biological activities. From this crude principle some 
tetranortriterpenes, including nimbi , nimbinin, nimbidi-
nin, nimbolide and nimbidic acid have been isolated12,20. 
Nimbidin and sodium nimbidate possess significant dose-
dependent anti-i flammatory activity against carrageenin-
induced acute paw oedema in rats and formalin-induced 
arthritis21,22. Antipyretic activity has also been reported 
and confirmed in nimbidin23. Oral administration of 
nimbidin demonstrated significant hypoglycaemic effect 
in fasting rabbits24. A significant antiulcer effect was 
observed with nimbidin in preventing acetylsalicylic 
acid, indomethacin, stress or serotonin-induced gastric 
lesions as well as histamine or cysteamine-induced duo-
denal ulcers25,26. Nimbidin can also suppress basal as 
well as histamine and carbachol-stimulated gastric acid 
output and may act s an antihistamine by blocking H2 
receptors, thereby helping as an antiulcer agent27. The 
spermicidal activity of nimbidin and nimbin (1) was 
reported in rats and human as early as 1959 (refs 28, 29). 
Nimbidin also demonstrated antifungal activity by inhi- 
 
biting the growth of Tinea rubrum30. In vitro, it can 
completely inhibit the growth of Mycobacterium tuber-
culosis and was also found to be bactericidal30. Diuretic 
activity was also reported for sodium nimbidinate in 
dogs31. Nimbolide (2) has been shown to exert anti-
malarial activity by inhibiting the growth of Plasmodium 
falciparum32,33. Nimbolide also shows antibacterial acti-
vity against S. aureus and S. coagulase34. 
Gedunin (3), isolated from neem seed oil has been 
r ported to possess both antifungal35 and antimalarial33 
activities. Azadirachtin (4), highly oxygenated C-seco-
meliacins isolated from neem seed and having strong 
antifeedant activity17,19,36, has been demonstrated to have 
antimalarial property as well. It is inhibitory to the deve-
lopment of malarial parasites37. Mahmoodin (5), a deoxy-
gedunin isolated from seed oil, has been shown to possess 
moderate antibacterial action against some strains of 
human pathogenic bacteria18. Condensed tannins from the 
bark contain gallic acid, (+) gallocatechin, (–) epicate-
chin, (+) catechin and epigallocatechin, of which gallic 
acid (6), (–) epicatechin (7) and catechin (8) are primarily 
responsible for inhibiting the generation of chemilumine-
scence by activated human polymorphonuclear neutrophil 
(PMN)38, indicating that these compounds inhibit oxi-
dative burst of PMN during inflammation. Three tricyclic  
 
 
Table 1. Some bioactive compounds from neem 
    
    
Neem compound Source Biological activity Reference 
        
Nimbidin  Anti-inflammatory 21 
  Antiarthritic 22 
  Antipyretic 23 
  Hypoglycaemic 24 
  Antigastric ulcer 25, 26 
  Spermicidal 29 
  Antifungal 30 
  Antibacterial 30 
  Diuretic 31 
Sodium nimbidate  Anti-inflammatory 21, 22 
Nimbin (1) Seed oil Spermicidal 28 
Nimbolide (2) Seed oil  Antibacterial 
Antimalarial 
32, 33 
34 
Gedunin (3) Seed oil  Antifungal  
Antimalarial 
35 
33 
Azadirachtin (4) Seed Antimalarial 37 
Mahmoodin (5) Seed oil  Antibacterial 18 
Gallic acid (6), (–) epicatechin (7) 
  and catechin (8)
Bark Anti-inflammatory and  
immunomodulatory 
38 
Margolone (9), margolonone (10)  
 and isomargolonone (11)
Bark Antibacterial 39 
Cyclic trisulphide (12) and  
 cyclic tetrasulphide (13)
Leaf Antifungal 40 
Polysaccharides  Anti-inflammatory 41 
Polysaccharides GIa (14), GIb Bark Antitumour 42 
Polysaccharides GIIa (15), GIIIa (16) Bark Anti-inflammatory 43 
NB-II peptidoglycan  Bark Immunomodulatory 44, 45 
    
    
Numbers in parentheses indicate structures shown in Figure 1. 
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diterpenoids, margolone (9), margolonone (10) and iso-
margolonone (11) isolated from neem stem bark are 
active against Klebsiella, Staphylocccus and Serratia 
species39. Sulphur-containing compounds such as cyclic 
trisulphide (12) and tetrasulphide (13) isolated from the 
steam distillate of fresh, matured neem leaves have 
antifungal activity against Trichophyton mentagrophy-
tes40. Several polysaccharides from neem exhibit various 
biological effects. A polysaccharide extracted from bark 
inhibits carrageenin-i duced inflammation in mouse41. 
Two water-soluble polysaccharides GIa (14) and GIb 
isolated from the bark of Melia azadirachta, demon-
strated strong antitumour effect with complete regression 
of the tumours, when administered in mice at a daily dose 
of 50 mg/kg for four days from 24 h after subcutaneous 
inoculation of Sarcoma-180 cells42. Two more poly-
sac harides, GIIa (15) and GIIIa (16) isolated from M. 
azadirachta bark also showed significant anti-inflam-
matory effect on carrageenin-induced oedema in mice43. 
Two polymers isolated from an aqueous extract of neem 
bark possess anticomplement activity, amongst which the 
compound NB-II, a peptidoglycan of lower molecular 
weight was found to be more potent44,45. Some active 
ingredients (phytosterol fraction) isolated from the lipid 
part of neem fruits, exhibit antiulcer activity in stress-
induced gastric lesions46. 
 
Figure 1. Structure of bioactive neem compounds. 
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Pharmacological actions of neem xtract 
Several pharmacological activities and medicinal appli-
cations of various parts of neem are well known16,47. 
Biological activity of neem is reported with the crude 
extracts and their different fractions from leaf, bark, root, 
seed and oil. However, crude extract of different parts of 
neem have been used as traditional medicine for the 
treatment of various diseases. 
Medicinal use of various parts of neem 
Various parts of the neem tree have been used as tradi-
tional ayurvedic medicine in India from time imme-
morial48. The medicinal utilities have been described, 
especially for leaf, fruit and bark4. Neem oil and the bark 
and leaf extracts have been therapeutically used as folk 
medicine to control leprosy, intestinal helminthiasis, 
respiratory disorders, constipation and also as a general 
health promoter49. Its use for the treatment of rheu-
matism, chronic syphilitic sores and indolent ulcer has 
also been evident3. Neem oil finds use to control various 
skin infections1. Bark, leaf, root, flower and fruit together 
cure blood morbidity, biliary afflictions, itching, skin 
ulcers, burning sensations and pthysis13. Some of the medi-
cinal attributes of various parts of neem50 as mentioned  
in ayurveda13,48 have been summarized in Table 2. 
However, apart from these uses, there are several reports 
on the biological activities and pharmacological actions 
of neem based on modern scientific investigations. 
 
Anti-inflammatory, antipyretic and analgesic activities: 
The chloroform extract of stem bark is effective against 
carrageenin- duced paw oedema in rat and mouse ear 
inflammation51. Inflammatory stomatitis in children is 
cured by the bark extract52. Antipyretic activity has been 
reported in neem oil30,53. A methanol extract of the leaves 
exerts antipyretic effect in male rabbits54. The plant also 
possesses analgesic activity mediated through opioid 
receptors in laboratory animals55. Anti-inflammatory and 
antipyretic activities in various extracts have been 
reviewed56. 
 
Immunostimulant activity: The aqueous extract of neem 
bark possesses anticomplement activity, acting both on 
the alternative as well as the classical pathway of com-
plement activation in human serum44. Recently, an 
aqueous extract of stem bark has been shown to enhance 
the immune response of Balb-c mice to sheep red blood 
cells in vivo57. The aqueous extract of leaf also possesses 
potent immunostimulant activity as evidenced by both 
humoral and cell-mediated responses58,59. Leaf extract at 
100 mg/kg after three weeks of oral administration causes 
higher IgM and IgG levels along with increased titer of 
antiovalbumin antibody59. Neem oil has been shown to 
possess immunostimulant activity by selectively acti-
vating the cell-mediated immune mechanisms to elicit an 
enhanced response to subsequent mitogenic or antigenic 
challenge60. 
 
Hypoglycaemic activity: Aqueous extract of neem leaves 
significantly decreases blood sugar level and prevents 
adrenaline as well as glucose-induced hyperglycaemia61. 
The aqueous leaf extract when orally fed, also produces 
hypoglycaemia in normal rats and decreased blood glu-
cose levels in experimentally-induced diabetes in rats62. 
Aqueous leaf extract also reduces hyperglycaemia in 
streptozotocin diabetes and the effect is possibly due to 
presence of a flavonoid, quercetin63. A significant hypo-
glycaemic effect was also observed by feeding neem oil 
to fasting rabbits24. Recently, hypoglycaemic effect was 
observed with leaf extract and seed oil, in normal as well 
as alloxan-i duced diabetic rabbits64. The possible mecha-
nisms underlying the hypoglycaemic activity of the aque-
ous leaf extract have also been discussed65,66. 
 
Antiulcer effect: Neem leaf aqueous extract produces 
antiulcer effect in rats exposed to rstraint – cold stress 
or ethanol orally by preventing mucus depletion and mast 
cell degranulation67. An aqueous extract of neem bark 
has been shown from our laboratory to possess highly 
potent antiacid secretory and antiulcer activity and the 
bioactive compound has been attributed to a glycoside68. 
 
Antifertility effect: Neem oil proved spermicidal against 
rhesus monkey and human spermatozoa in vitr69. In vivo 
studies showed that intravaginal application of neem oil 
prior to coitus can prevent pregnancy69. Antifertility 
effect of neem oil has also been studied and suggeste to 
be a novel method of contraception70–72. Oral adminis-
tration of aqueous extract of neem leaf also shows 
Table 2. Some medicinal uses of neem as mentioned in ayurveda 
  
  
Part Medicinal use 
    
Leaf Leprosy, eye problem, epistaxis, intestinal 
worms, anorexia, biliousness, skin ulcers. 
Bark Analgesic, alternative and curative of fever. 
Flower Bile suppression, elimination of intestinal 
worms and phlegm. 
Fruit Relieves piles, intestinal worms, urinary dis-
order, epistaxis, phlegm, eye problem, diabe-
tes, wounds and leprosy. 
Twig Relieves cough, asthma, piles, phantom 
tumour, intestinal worms, spermatorrhoea, 
obstinate urinary disorder, diabetes. 
Gum Effective against skin diseases like ring-
worms, scabies, wounds and ulcers.
Seed pulp Leprosy and intestinal worms. 
Oil Leprosy and intestinal worms. 
Root, bark, leaf, flower  
 and fruit together 
Blood morbidity, biliary afflictions, itching, 
skin ulcer, burning sensation and leprosy. 
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antifertility effect in mice73. Purified neem seed extract 
(Praneem) has also been demonstrated to abrogate 
pregnancy in both baboons and bonnet m k ys, when 
administered orally74. From the hexane extract of neem 
seed, an active fraction containing six components has 
been found to completely abrogate pregnancy in rodents 
when given orally up to a concentration of 10%, with no 
apparent side effect75. The effect is possibly due to 
activation of cell-mediated immune reaction. The mecha-
nism of action of neem oil appears to be non-hormonal, 
probably mediated through its spermicidal effect and may 
have less side effects than steroidal contraceptives. 
 
Antimalarial activity: Neem seed and leaf extracts are 
effective against malarial parasites33,76. Components of 
the alcoholic extracts of leaves and seeds are effective 
against both chloroquin-resistant and sensitive strains of 
malarial parasite77. Recently, neem seed extract and i s 
purified fractions have been shown to inhibit growth  
and development of asexual and sexual stages of drug-
sensitive and resistant strains of the human malarial 
parasite P. falciparum78. 
 
Antifungal activity: Extracts of neem leaf, neem oil and 
seed kernels are effective against certain human fungi, 
including Trichophyton, Epidermophyton, Microsporum, 
Trichosporon, Geotricum and Candida79. High anti-
mycotic activity with extracts of different parts of neem 
has already been reported56. 
 
Antibacterial activity: Oil from the leaves, seeds  
and bark possesses a wide spectrum of antibacterial  
action against Gram-negative and Gram-positive micro-
organisms, including M. tuberculosis and streptomycin-
resistant strains80. In vitro, it inhibits Vibrio cholerae, 
Klebsiella pneumoniae, M. tuberculosis and M. pyo-
genes81. Antimicrobial effects of neem extract have been 
demonstrated against Streptococus mutans and S. fae-
calis82. NIM-76, a new vaginal contraceptive from neem 
oil showed inhibitory effect on the growth of various 
pathogens, including bacteria, fungi and virus83. Recently, 
the antibacterial activity of neem seed oil was assessed  
in vitro against 14 strains of pathogenic bacteria84. 
 
Antiviral activity: Aqueous leaf extract offers antiviral 
activity against Vaccinia virus85, Chikungemya and mea-
sles virus in vitro86. The antiviral and virucidal effects of 
the methanolic extract of neem leaves (NCL-11) have 
recently been demonstrated against group-B Coxsackie 
viruses87. NCL-11 inhibits plaque formation in different 
antigenic types of Coxsackie virus B at a concentration of 
1 mg/ml at 96 h in vitro. Further studies indicated that 
NCL-11 is most effective in Coxsackie virus B-4 as a 
virusidal agent, in addition o its interference at the early 
events of its replication. 
Anticarcinogenic activity: Neem leaf aqueous extract 
effectively suppresses oral squamous cell carcinoma 
induced by 7,12-dimethylbenz[a]anthracene (DMBA), as 
r vealed by reduced incidence of neoplasm88. Neem may 
exert it  chemopreventive effect in the oral mucosa by 
modulation of glutathione and its metabolizing enzymes. 
That eem leaf extract exerts its protective effect in N-
methyl-N¢-nitro-N-nitrosoguanidine (MNNG) (a carcino-
genic material)-induced oxidative stress has also been 
demonstrated by the reduced formation of lipid peroxides 
enhanced level of antioxidants and detoxifying 
enzymes in the stomach, a primary target organ for 
MNNG as well as in the liver and in circulation89,90. 
 
Hepatoprotective activity: The aqueous extract of neem 
leaf was found to offer protection against paracetamol-
induced liver necrosis in rats91. The elevated levels of 
serum aspartate aminotransferase (AST), alanine amino-
transferase (ALT) and gamma glutamyl tr nspeptidase 
(GGT) indicative of liver damage, were found to be sig-
nificantly reduced on administration of the neem leaf 
aqueous extract. 
 
Antioxidant activity: The antioxidant activity of neem 
seed extract has been demonstrated in vivo uring horse-
grain ermination, which is associated with low levels of 
lipooxygenase activity and lipid peroxides92. An antioxi-
dant principle has also been isolated, which is a potent 
inhibitor of plant lipooxygenases. 
 
Effect on central nervous system: Varying degrees of 
central nervous system (CNS) depressant activity in mice 
was observed with the leaf extract93. Fractions of acetone 
extract of leaf showed significant CNS depressant acti-
vity94. Leaf extract up to a dose of 200 mg/kg body weight 
produces significant anxiolytic activity in rats95. The 
crude ethanolic extract of stem bark and root bark showed 
hypotensive, spasmolytic and diuretic activities96,97. 
Clinical studies and plausible medicinal 
applications of neem 
Although a large number of studies have been carried out 
on various biological activities of neem extracts and 
some of the isolated compounds in several animal models, 
a few reports are available on clinical studies with  
the extracts or the compounds and their medicinal 
applications. 
N em extract 
Clinical studies with the dried neem leaf extract indicated 
its effectiveness to cure ringworm, eczema and scabies. 
Lotion derived from neem leaf, when locally applied, can 
cure these dermatological diseases within 3–4 days in 
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acute stage or a fortnight in chronic case98,99. A paste 
prepared with neem and turmeric was found to be 
effective in the treatment of scabies in nearly 814 
people100. In 97% of cases, the paste was found to cure 
scabies within 3–15 days of treatment without any 
adverse effect. Neem leaf extract has been prescribed for 
oral use for the treatment of malaria by Indian ayurvedic 
practitioners from time immemorial. Dried neem leaves 
in the form of tea are used by the people of Nigeria and 
Haiti to treat this disease101. Recently, a clinical trial has 
been carried out to see the efficacy of neem extract to 
control hyperlipidemia in a group of malarial patients 
severely infected with P. falciparum102. The lipid level, 
especially cholesterol, was found to be lower during 
therapy when compared to non-malaria patients. This is a 
report on malaria patients being treated with the neem 
extract on plasma lipid level during infection. Several 
clinical studies have been reported with the neem oil. 
Application of neem oil on the hair has been shown to 
kill head lice101. Reports are available regarding the use 
of neem to treat patients suffering from various forms of 
cancer103. One patient with parotid tumour and another 
with epidermoid carcinoma have responded successfully 
when treated with neem seed oil104. Although in trials 
neem oil has been shown to have antimicrobial effect to 
inhibit many species of pathogenic bacteria, including S. 
aureus and Salmonella typhora, it has not been consi-
dered as antibiotic due to some limitations101. C ide-
rable clinical trials have been done on the antifertility 
effect of neem oil. NIM-76, a refined product from neem 
oil, was studied in 10 human volunteers, where intra-
vaginal application before sexual intercourse could prevent 
pregnancy with no adverse effect on vagina, cervix and 
uterus101. After demonstrating the antifertility effect of 
intrauterine neem oil treatment (IUNT) in bonnet monkeys 
with no apparent side effects71, phase I clinical trials 
were conducted on Praneem Vilci (PV)105, a purified 
neem oil preparation on eighteen healthy tubectomized 
women to evaluate the safety after a single intrauterine 
instillation of PV and to determine the effects of its 
coadministration on anti-hCG response to the hetero-
species dimer (HSD) hCG vaccine. Haematological and 
biochemical profiles, mid-luteal serum progesterone level 
and ovulatory status were determined before and after 
intrauterine treatment with PV. Except one woman show-
ing nonspecific endometritis, no significant adverse effect 
was observed in other women and all women receiving 
PV and HSD vaccine produced antibodies against hCG. 
The data suggested that intrauterine treatment of PV is 
safe. The authors are unaware whether phase II and phase 
III clinical trials have been carried out. A polyherbal 
pessary (Praneem polyherbal pessary) has been deve-
loped using some purified ingredients from neem leaves, 
Sapindus mukerossi and Mencitrata oil, which shows 
spermicidal action in vitro on human sperm andin vivo 
on post-coital tests in women106,107. The formulation also 
has antimicrobial activity. Phase I clinical trials have 
been completed in India, Egypt and the Dominician 
Republic. These indicate the safety of its use with bene-
ficial action in invaginosis due to microbial infection106. 
In most women, the pessary also prevented migration of 
sperm into the cervical mucus107. Praneem pessary has 
thus potential for the development of contraceptive devices. 
Neem compound 
There have been very few reports on the clinical trials 
done with bioactive compounds isolated from neem. 
Sodium nimbidinate, the sodium salt of nimbidin, the 
main bitter principle isolated from neem seed oil, has 
been shown to act as a potent diuretic under various clini-
cal conditions108. In a limited clinical trial, oral admin-
istration of 100 mg nimbidin three times daily for 10 
consecutive days to tropical eosinophilia patients, caused 
25% reduction in total eosinophil count with a marked 
symptomatic relief109. 
Safety evaluation with various parts of neem and 
neem products 
Various studies have been reported on he safety evalu-
ation of different parts of neem as well as its various 
biologically active products98,110–112. As the details of 
these studies are beyond the scope of this review, only 
the major findings have been presented. 
Neem bark 
Neem stem bark extract shows lethal effect in three com-
mon snail species Biomphalaria pfeifferi, Bulinus trunca-
tus and Lymnaea natalensis and against fish, Aphyosemon 
giardneri113. Methanolic extract of neem bark demonstra-
ted oral LD50 at about 13 g/kg in acute toxicity studies on 
mice98. Detailed toxicity studies have recently been 
conduct d in rats with the neem bark aqueous extract114 
as an extension of our studies showing antiacidsecretory–
antiulcer activity of the bark extract68. In 14-day oral 
toxicity studies with 2 g/kg body weight, no lethal effect 
was observed, with no apparent change in relative organ 
weight, hematological parameters, enzyme levels and 
histopathology of several organs. The subacute (28 days) 
oral toxicity studies with both 0.05 and 0.1 g/kg body 
weight also revealed no abnormalities in the above-
mentioned parameters. Acute and subacute (14 days) 
t xicity studies in the authors’ laboratory on mice with 1 
g/kg and 0.6 g/kg body weight respectively also showed 
no lethal effect with the bark extract. 
Neem seed 
Various neem seed preparations such as aqueous neem 
seed kernel extract demonstrated toxicity to Oreochromis 
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niloticus (tilapia) and Cyprinus carpio (carp)110. Nearly 
60% mortality was observed in white leghorn chicks 
within a day of feeding powdered ripe neem berry aque-
ous extract110,115. Another feeding trial with neem seed 
meal (2.5%) on chicks110 indicated mild to severe changes 
in kidney, liver, spleen, intestine and heart. An aqueous 
extract of neem seed kernel (1 ml/100 g body weight 
daily of a 50 g/l solution) produces trypsin inhibitory 
activity in weanling rats110,116. Retardation of spermato-
genesis was observed by feeding neem seed cake to 
rats110. Calves fed with neem seed cake showed reduced 
haemoglobin content in the blood, along with dep-
ression110. 
Neem oil 
Neem oil shows toxicity to fish like tilapia and carp, with 
an LC50 of 1124.6 and 302.7 ppm respectively
110. Oral 
administration of neem oil at 200 mg/rat produces severe 
hypoglycaemic effect110. Neem seed oil showed acute 
toxicity in rats and rabbits with LD50 of 14 ml/kg and 
24 ml/kg respectively, the possible target organs for toxic 
effects being the CNS and the lungs117. Neem seed  
oil produces toxic effect in humans in several isolated 
cases98,110,118. Neem oil intoxication by humans produces 
diarrhoea, nausea, vomiting, acidosis, encephalopathy, 
etc.110,118. These toxic effects might be due to presence of 
aflatoxin and other toxic compounds present in neem oil. 
Mechanistic investigations indicate that neem oil un-
couples mitochondrial oxidative phosphorylation, thus 
inhibiting the respiratory chain. It also decreases intra-
mitochondrial levels of acetyl CoA and acid-soluble CoA 
esters and reduces the mitochondrial ATP content98,110,119. 
Neem leaves 
Methanolic extract of neem leaf exhibits oral toxicity  
in mice98, showing signs of ill health and discomfort, 
gastrointestinal spasms, apathy, hypothermia and termin l 
convulsions, leading to death. Intravenously administered 
aqueous leaf extract at a dose greater than 40 mg/kg body 
weight produces toxic manifestation leading to death in 
guinea pigs98. Successive doses of 5–200 mg/kg reduces 
heart rate and increased th  arterial pulse rate in guinea 
pigs110. Aqueous leaf extract also shows antifertility 
effect in mice when given through the oral route73,98. 
Table 3. Safety evaluation of different parts of neem
    
    
 
Part 
 
Toxic/adverse effect 
Animal in which toxicity  
is manifested 
 
Reference 
        
Bark Lethal toxicity Snail and fish  
Mice 
113 
98 
Seed Lethal toxicity Tilapia and carp 
White leghorn chicks 
110 
110, 115 
 Mild to severe changes in kidney,  
liver, spleen, intestine a d heart 
Chick 110 
 Trypsin inhibitory activity Weaning rat 110, 116 
 Antispermatogenesis Rat 110 
 Reduced haemoglobin content and  
growth depression 
Calf 110 
Oil Lethal toxicity Tilapia and carp 110 
 Acute toxicity Rat, rabbit 117 
 Severe hypoglycaemia  Rat 24, 64, 110 
 Produces vomiting, diarrhoea,  
drowsiness, acidosis, encephalopathy 
Human 98, 110, 118 
 Spermicidal Rhesus monkey and human 69 
 Antifertility Baboons and monkey 
Rodent 
74 
75 
Leaf Lethal toxicity Mice, guinea pig 98 
 Reduced heart rate and increased pulse rate Guinea pig 110 
 CNS-depressant Mice 93 
 Hepatonephropathy Hisex chick 120 
 Genotoxicity Mice 121 
 Antifertility Mice 73, 98 
 Decreased sperm count and motility Rat 122 
 Antiandrogenic Rat 123 
 Hypoglycaemia Rat, rabbit 62, 64 
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Brown hisex chicks, when fed with a diet containing 2% 
and 5% neem leaf from their 7th to 35th day after birth 
developed hepatonephropathy and significant change in 
blood parameters120. Crude neem leaf extract causes 
genotoxicity in male mice germ cell at a dose of 0.5–
2 g/kg body weight for 6 weeks. Some structural change 
in meiotic chromosomes along with chromosome strand 
breakage or spindle disturbances and abnormal regulation 
of genes controlling sperm shape were observed121. N em 
leaf extract when administered for 48 days in albino rats 
causes decrease in sperm count, sperm motility and forward 
velocity, probably due to androgen deficiency122. Oral 
administration of 20–6  mg dry leaf powder for 24 days 
in rats causes decrease in the weight of seminal vesicle 
and ventral prostrate, and regressive changes of the histo-
logical parameters through its antiandrogenic p p rty123. 
Some toxicological manifestations of various parts of 
neem have been presented in Table 3.  
Safety evaluation of neem compounds and marketed 
formulations 
Nimbidin produces sub-acute toxicity in adult rats after 
daily administration of 25, 50 or 100 mg/kg for six 
weeks98. A significant hypoglycaemic effect was obser-
ved by feeding nimbidin to fasting rabbits24. Nimbidin 
also has spermicidal activity28,29. Nimbolide, a major che-
mical component of neem seed oil, and nimbic acid were 
found to be toxic to mice when given intravenously or 
intraperitoneally110,124. They are, however, less toxic to 
rats and hamster124. Nimbolide and nimbic acid at a lethal 
dose cause death in most animals by dysfunction of 
kidney, small intestine and liver as well as by marked and 
sudden drop of arterial blood pressure. Nimbolide shows 
potent cytotoxic effect125 on N1E-115 neuroblastoma 
(mouse), 143B.TK-osteosarcoma (human) and Sf9 (insect)
cultured cell lines with IC50 value of 4–10 mM. Other 
limonoids like epoxyazadiradione and salanin show cyto-
toxic effect at IC50 value of 27 and 112 mM respectively. 
Nimbidin, deacetylnimbin and azadirachtin are practi-
cally nontoxic. Acetylcholinesterase (AchE), Na+–K+, 
and Ca++–ATPase are significantly inhibited, while Mg2+–
ATPase level increases significantly in rat brain when 
treated orally with 80, 160 and 320 mg/kg of vepacide, an 
active ingredient from neem seed oil, daily for 90 days126. 
Several studies were performed with Margosan ‘O’, an 
extract of neem seeds. However, no apparent toxic mani-
festations were noticeable in rats or mice110. LC50 of 
Margosan ‘O’ is more than 2 ml/kg in albino rabbits 
when tested for acute dermal toxicity98. However, Mar-
gosan ‘O’ showed minimal irritation in both eyes98 when 
applied to one washed and one unwashed eye of albino 
rabbits over seven days. NIM-76, a volatile fraction of 
neem oil, possesses antifertility activity when applied 
before coitus in rats, rabbits and rhesus monkeys127. 
Conclusion 
Neem, the versatile medicinal plant is the unique source 
of various types of compounds having diverse chemical 
structure. Very little work has been done on the bio-
logical activity and plausible medicinal applications of 
these compounds and hence extensive investigation is 
needed to exploit their therapeutic utility to combat 
diseases. A drug-development programme should be 
u dert ken to develop modern drugs with the compounds 
isolated from neem. Although crude extracts from vari-
ous parts of neem have medicinal applications from time 
immemorial, modern drugs can be developed after 
ext nsive investigation of its bioactivity, mechanism of 
action, pharmacotherapeutics, toxicity and after proper 
standardization and clinical trials. As the global scenario 
is now changing towards the use of nontoxic plant 
products having traditional medicinal use, development 
of modern drugs from neem should be emphasized for the 
control of various diseases. In fact, time has come to 
make good use of centuries-old knowledge on neem 
through modern approaches of drug development. For the 
last few years, there has been an increasing trend and 
awareness in neem research. Quite a significant amount 
of research has already been carried out during the past 
few decades in exploring the chemistry of different parts 
of neem. Several therapeutically and industrially useful 
preparations and compounds have also been marketed, 
which generates enough encouragement among the scien-
tists in exploring more information about this medicinal 
plant. An extensive research and development work 
s ould be undertaken on neem and its products for their 
better economic and therapeutic utilization. 
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